Showing 12,561 - 12,580 results of 16,807 for search '(( 50 ((we decrease) OR (teer decrease)) ) OR ( 100 ((mean decrease) OR (a decrease)) ))', query time: 0.54s Refine Results
  1. 12561

    Changes in disease burden in Poland between 1990–2017 in comparison with other Central European countries: A systematic analysis for the Global Burden of Disease Study 2017 by Maria Gańczak (8519883)

    Published 2020
    “…For both YLLs and YLDs, greater relative declines were observed for females. There was a large decrease in communicable, maternal, neonatal, and nutritional disease DALYs (48.2%; 46.3–50.4). …”
  2. 12562

    Visualization_2.mp4 by Pedro Mece (4707142)

    Published 2023
    “…The image sequence was acquired at 100Hz and displayed here at 25Hz.…”
  3. 12563
  4. 12564

    Table_1_The effects of multiwalled carbon nanotubes and Bacillus subtilis treatments on the salt tolerance of maize seedlings.docx by Ying Luo (381053)

    Published 2022
    “…The dose-dependent effects of MWCNTs were confirmed: 20 mg/L MWCNTs significantly promoted the accumulation of osmolytes in maize, particularly K<sup>+</sup> in the leaves and roots, increased the leaf indoleacetic acid content, decreased the leaf abscisic acid content; but the above-mentioned promoting effects decreased significantly in 50 mg/L MWCNTs-treated plants. …”
  5. 12565

    Data_Sheet_1_Initial risk factors, self-compassion trajectories, and well-being outcomes during the COVID-19 pandemic: A person-centered approach.pdf by Hali Kil (14584304)

    Published 2023
    “…Introduction<p>We investigated whether initial risk classes and heterogeneous trajectories of self-compassion over the course of the pandemic may impact well-being outcomes 1 year into the pandemic.…”
  6. 12566
  7. 12567

    Image1_Nitazoxanide, an Antiprotozoal Drug, Reduces Bone Loss in Ovariectomized Mice by Inhibition of RANKL-Induced Osteoclastogenesis.tif by Chang-hong Li (11816780)

    Published 2023
    “…The present study found that NTZ potently inhibited osteoclast formation at the early stage of receptor activator of NF-κB ligand-induced osteoclastogenesis in a concentration-dependent manner at a non-growth inhibitory concentration. …”
  8. 12568

    Table1_Nitazoxanide, an Antiprotozoal Drug, Reduces Bone Loss in Ovariectomized Mice by Inhibition of RANKL-Induced Osteoclastogenesis.docx by Chang-hong Li (11816780)

    Published 2023
    “…The present study found that NTZ potently inhibited osteoclast formation at the early stage of receptor activator of NF-κB ligand-induced osteoclastogenesis in a concentration-dependent manner at a non-growth inhibitory concentration. …”
  9. 12569

    Image3_Nitazoxanide, an Antiprotozoal Drug, Reduces Bone Loss in Ovariectomized Mice by Inhibition of RANKL-Induced Osteoclastogenesis.tif by Chang-hong Li (11816780)

    Published 2021
    “…The present study found that NTZ potently inhibited osteoclast formation at the early stage of receptor activator of NF-κB ligand-induced osteoclastogenesis in a concentration-dependent manner at a non-growth inhibitory concentration. …”
  10. 12570

    Rumen parameters and intake in goats fed cassava chips and alfalfa by Raquel Ornelas Marques (10446687)

    Published 2021
    “…Rumen pH and SCFA production were influenced by the collection times, presenting a high pH (6.29) at the first measurement (07 h 00) and then decreasing, thus influencing SCFA production throughout the day.Acetic acid and total SCFA production were influenced by the diets, with the highest values for the cassava/alfalfa diet (68.03 and 93.64 mM 100 mM-1, respectively) and the lowest values for the corn/soybean diet (55.40 and 76.03 mM 100 mM-1, respectively).Nutrient digestibility was also influenced by diets, with those containing cassava and cassava/alfalfa, providing the greatest effective degradability (57.57 to 0.02 h-1 and 53.49 to 0.05 h-1; 57.25 to 0.02 h-1and 53.26 to 0.05 h-1, respectively). …”
  11. 12571

    Image2_Nitazoxanide, an Antiprotozoal Drug, Reduces Bone Loss in Ovariectomized Mice by Inhibition of RANKL-Induced Osteoclastogenesis.tif by Chang-hong Li (11816780)

    Published 2023
    “…The present study found that NTZ potently inhibited osteoclast formation at the early stage of receptor activator of NF-κB ligand-induced osteoclastogenesis in a concentration-dependent manner at a non-growth inhibitory concentration. …”
  12. 12572

    Data_Sheet_1_Incidence of Guillain–Barré syndrome in South Korea during the early COVID-19 pandemic.docx by Sun Ah Choi (8825594)

    Published 2023
    “…</p>Methods<p>We conducted a nationwide population-based retrospective GBS cohort study using data from the Health Insurance Review and Assessment Service of Korea. …”
  13. 12573

    Image3_Nitazoxanide, an Antiprotozoal Drug, Reduces Bone Loss in Ovariectomized Mice by Inhibition of RANKL-Induced Osteoclastogenesis.tif by Chang-hong Li (11816780)

    Published 2023
    “…The present study found that NTZ potently inhibited osteoclast formation at the early stage of receptor activator of NF-κB ligand-induced osteoclastogenesis in a concentration-dependent manner at a non-growth inhibitory concentration. …”
  14. 12574

    DataSheet1_Nitazoxanide, an Antiprotozoal Drug, Reduces Bone Loss in Ovariectomized Mice by Inhibition of RANKL-Induced Osteoclastogenesis.docx by Chang-hong Li (11816780)

    Published 2023
    “…The present study found that NTZ potently inhibited osteoclast formation at the early stage of receptor activator of NF-κB ligand-induced osteoclastogenesis in a concentration-dependent manner at a non-growth inhibitory concentration. …”
  15. 12575

    Image1_Nitazoxanide, an Antiprotozoal Drug, Reduces Bone Loss in Ovariectomized Mice by Inhibition of RANKL-Induced Osteoclastogenesis.tif by Chang-hong Li (11816780)

    Published 2021
    “…The present study found that NTZ potently inhibited osteoclast formation at the early stage of receptor activator of NF-κB ligand-induced osteoclastogenesis in a concentration-dependent manner at a non-growth inhibitory concentration. …”
  16. 12576

    DataSheet1_Nitazoxanide, an Antiprotozoal Drug, Reduces Bone Loss in Ovariectomized Mice by Inhibition of RANKL-Induced Osteoclastogenesis.docx by Chang-hong Li (11816780)

    Published 2021
    “…The present study found that NTZ potently inhibited osteoclast formation at the early stage of receptor activator of NF-κB ligand-induced osteoclastogenesis in a concentration-dependent manner at a non-growth inhibitory concentration. …”
  17. 12577

    Data_Sheet_1_Incidence of Guillain–Barré syndrome in South Korea during the early COVID-19 pandemic.docx by Sun Ah Choi (8825594)

    Published 2023
    “…</p>Methods<p>We conducted a nationwide population-based retrospective GBS cohort study using data from the Health Insurance Review and Assessment Service of Korea. …”
  18. 12578

    Image2_Nitazoxanide, an Antiprotozoal Drug, Reduces Bone Loss in Ovariectomized Mice by Inhibition of RANKL-Induced Osteoclastogenesis.tif by Chang-hong Li (11816780)

    Published 2021
    “…The present study found that NTZ potently inhibited osteoclast formation at the early stage of receptor activator of NF-κB ligand-induced osteoclastogenesis in a concentration-dependent manner at a non-growth inhibitory concentration. …”
  19. 12579

    Table1_Nitazoxanide, an Antiprotozoal Drug, Reduces Bone Loss in Ovariectomized Mice by Inhibition of RANKL-Induced Osteoclastogenesis.docx by Chang-hong Li (11816780)

    Published 2021
    “…The present study found that NTZ potently inhibited osteoclast formation at the early stage of receptor activator of NF-κB ligand-induced osteoclastogenesis in a concentration-dependent manner at a non-growth inhibitory concentration. …”
  20. 12580

    Image_1_Cortico-Striatal Oscillations Are Correlated to Motor Activity Levels in Both Physiological and Parkinsonian Conditions.pdf by Cristóbal Moënne-Loccoz (9237122)

    Published 2020
    “…In motor cortices and striata, we observed a robust correlation between the motion index and the oscillatory power in two main broad frequency ranges: a low-frequency range [5.0–26.5 Hz] was negatively correlated to motor activity, whereas a high-frequency range [35.0–79.9 Hz] was positively correlated. …”